Literature DB >> 33950053

Radical-initiated P,P-metathesis reactions of diphosphanes: evidence from experimental and computational studies.

Callum Branfoot1, Tom A Young2, Duncan F Wass3, Paul G Pringle1.   

Abstract

By combining the diphosphanes Ar2P-PAr2, where Ar = C6H5, 4-C6H4Me, 4-C6H4OMe, 3,5-C6H3(CF3)2, it has been shown that P,P-metathesis generally occurs rapidly under ambient conditions. DFT calculations have shown that the stability of unsymmetrical diphosphanes Z2P-PZ'2 is a function of the difference between the Z and Z' substituents in terms of size and electronegativity. Of the mechanisms that were calculated for the P,P-metathesis, the most likely was considered to be one involving Ar2P˙ radicals. The observations that photolysis increases the rate of the P,P-metatheses and TEMPO inhibits it, are consistent with a radical chain process. The P,P-metathesis reactions that involve (o-Tol)2P-P(o-Tol)2 are anomalously slow and, in the absence of photolysis, were only observed to take place in CHCl3 and CH2Cl2. The role of the chlorinated solvent is ascribed to the formation of Ar2PCl which catalyses the P,P-metathesis. The slow kinetics observed with (o-Tol)2P-P(o-Tol)2 is tentatively attributed to the o-CH3 groups quenching the (o-Tol)2P˙ radicals or inhibiting the metathesis reaction sterically.

Entities:  

Year:  2021        PMID: 33950053     DOI: 10.1039/d1dt01013a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Stability of Carbocyclic Phosphinyl Radicals: Effect of Ring Size, Delocalization, and Sterics.

Authors:  Anna Ott; Péter R Nagy; Zoltán Benkő
Journal:  Inorg Chem       Date:  2022-10-04       Impact factor: 5.436

2.  Exploring the Reactivity of Unsymmetrical Diphosphanes toward Heterocumulenes: Access to Phosphanyl and Phosphoryl Derivatives of Amides, Imines, and Iminoamides.

Authors:  Natalia Szynkiewicz; Jarosław Chojnacki; Rafał Grubba
Journal:  Inorg Chem       Date:  2022-06-14       Impact factor: 5.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.